Acquiring Company
Zoar Ltd
Acquired Company
Impact BioMedical
West HenriettaBiotechnologyHealth CareBiotechnologyHealth CareDescription
Impact BioMedical Inc. and Zoar Ltd. are planning a merger that will create a new company with extensive expertise in pharmaceuticals. Following the completion of the merger, Impact stockholders will receive shares of Zoar Ltd. The merger aims to enhance capabilities in manufacturing and clinical development for critical drugs.
Quick answer
Zoar Ltd is acquiring Impact BioMedical, announced September 11, 2026.
- How much did Zoar Ltd pay for Impact BioMedical?
- The deal value was not disclosed.
- What does Zoar Ltd do?
- Zoar Ltd. specializes in the production of pharmaceutical ingredients and intermediates.
- Where are Zoar Ltd and Impact BioMedical based?
- Impact BioMedical is based in West Henrietta, New York, United States.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Real Diagnostics acquires SimplyTest for oral health (October 22, 2026)
- Cencora to acquire American Oncology Network (October 21, 2026)
- Curium US Holdings LLC to Acquire Lantheus Holdings, Inc. (October 21, 2026)
- Merck KGaA to acquire Silence Therapeutics for $1.3B, $1.3B (October 19, 2026)
- Vivos Therapeutics Acquires SOD Sciences in Strategic Asset Exchange (October 15, 2026)
- Alaunos Therapeutics acquires Velaris Therapeutics (October 13, 2026)
Who to call at Zoar Ltd, and when
When Zoar Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Zoar Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Zoar Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Zoar Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zoar Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Impact BioMedical?
Impact BioMedical was acquired by Zoar Ltd. The deal was reported on September 11, 2026. Zoar Ltd. specializes in the production of pharmaceutical ingredients and intermediates. The company is poised to contribute expertise in human health and wellness markets. Zoar Ltd is privately held and operates in Biotechnology.
When did Zoar Ltd acquire Impact BioMedical?
Zoar Ltd's acquisition of Impact BioMedical was reported on September 11, 2026. Impact BioMedical Inc. and Zoar Ltd. are planning a merger that will create a new company with extensive expertise in pharmaceuticals. Following the completion of the merger, Impact stockholders will receive shares of Zoar Ltd. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Impact BioMedical do?
Impact BioMedical Inc. operates in the biotechnology sector, focusing on the development and commercialization of innovative biohealth solutions. It is publicly traded (IBO), operating in Biotechnology, and is based in West Henrietta.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.